-
Loading metrics
Open Access
Peer-reviewed
Research Article
Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation
-
Cheryl Carson,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Pichai Raman,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Jennifer Tullai,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Lei Xu,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Martin Henault,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Emily Thomas,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Sarita Yeola,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Jianmin Lao,
Affiliation Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America
⨯ -
Mark McPate,
Affiliation Novartis Institutes for Biomedical Research, Horsham, United Kingdom
⨯ -
J. Martin Verkuyl,
Affiliation Novartis Institutes for Biomedical Research, Horsham, United Kingdom
⨯ -
George Marsh,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Jason Sarber,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Adam Amaral,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Scott Bailey,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Danuta Lubicka,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Helen Pham,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Nicolette Miranda,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Jian Ding,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Hai-Ming Tang,
Affiliation Novartis Institutes for Biomedical Research, East Hanover, New Jersey, United States of America
⨯ -
Haisong Ju,
Affiliation Novartis Institutes for Biomedical Research, East Hanover, New Jersey, United States of America
⨯ -
Pamela Tranter,
Affiliation Novartis Institutes for Biomedical Research, Horsham, United Kingdom
⨯ -
Nan Ji,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Philipp Krastel,
Affiliation Novartis Institutes for Biomedical Research, Basel, Switzerland
⨯ -
Rishi K. Jain,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Andrew M. Schumacher,
Affiliation Genomics Institute of the Novartis Research Foundation, San Diego, California, United States of America
⨯ -
Joseph J. Loureiro,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Elizabeth George,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Giuliano Berellini,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Nathan T. Ross,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Simon M. Bushell,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ -
Gül Erdemli,
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ - [ ... ],
-
Jonathan M. Solomon
* E-mail: jonathan.solomon@novartis.com
Affiliation Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America
⨯ - [ view all ]
- [ view less ]
Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation
- Cheryl Carson,
- Pichai Raman,
- Jennifer Tullai,
- Lei Xu,
- Martin Henault,
- Emily Thomas,
- Sarita Yeola,
- Jianmin Lao,
- Mark McPate,
- J. Martin Verkuyl
- Published: June 22, 2015
- https://doi.org/10.1371/journal.pone.0127498